TrialAlcohol, clinical & experimental research2025

Effect of the GLP-1 receptor agonist exenatide on pro-inflammatory and metabolic biomarkers in individuals with alcohol use disorder: Post hoc results from a randomized, double-blinded, placebo-controlled clinical trial.

Malthe E B Hviid et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.